HIGHLIGHTS
- who: Timothy Patrick Jenkins from the Department of and Biomedicine, Technical University of Denmark, Lyngby, Denmark have published the Article: Cost of Manufacturing for Recombinant Snakebite Antivenoms, in the Journal: (JOURNAL)
- what: The authors compare the theoretical cost of manufacture for the active_pharmaceutical_ingredient (API) with the cost of manufacture for the final drug product (FDP), as well as explore the relation between cost of manufacture and the molecular sizes of different antibody formats with the purpose of highlighting the influence of the number of toxin binding_sites per mass unit for different types of antibodies.
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.